10.15.18 Porphyrias Flashcards
These are a group of metabolic disorders resulting from a mutation in one of the enzymes in the heme biosynth pathway that leads to the accumulation of toxic metabolites; inherited/sporadic
Porphyria
Toxic metabolites from the heme biosynth pathways that have no useful function and act as highly reactive oxidants/damage tissue
Porphyrins
First (and rate-limiting) enzyme in heme synthesis pathway
mitochondrial enzyme that catalyzes the conversion of glycine and succinyl CoA to form delta-aminolevulinic acid and requires pyridoxal-5’-phosphate as a cofactor
Aminolevulinic acid synthetase (ALAS)
How can we induce ALAS1?
Why do we care?
- Depletion of the hepatic pool of heme
- Drugs, hormones which induce CYPs (and ALAS1)
- Caloric and carbohydrate restriction
- Metabolic stress, may induce hepatic heme oxygenase and accelerate heme destruction
Bad if you have porphyria and toxic metabolites from ALAS production form
What is Acute Intermittent Porphyria caused by?
Deficiency of hepatic PBG deaminase
Pattern of inheritance for AIP?
Autosomal dominant with low penetrance
In addition to low levels of PBGD what else does AIP require?
Induction of ALAS1
What are clinical features of an acute attack for AIP?
- Abdominal pain
- High HR/BP
- No inflammatory signs
- Sensory/motor neuropathy
- Insomnia
- Seizure
- Increase catecholamines
- SIADH- Hyponatremia
- Dark/reddish brown urine
- Bulbar paralysis, respiratory impairment, death
What are exacerbating factors of an acute attack?
- Drugs
- Crash diets
- Endogenous hormones
- Cigarette smoking
- Metabolic stresses
How do you diagnose AIP?
- Send urine for PBG and ALA to see if they’re elevated
- If markedly elevated send PBG deaminase enzyme activity
- DON’T be fooled by elevation in urine/stool porphyrins
How do you treat AIP?
- Withdraw unsafe meds
2. IV 10% glucose and hematin
How does Hematin work?
Reduces ALA/porphyrin by negative feedback inhibition on ALA synthetase
Degradation products binding can cause adverse effects of low platelets (thrombophlebitis, anticoagulation, thrombocytopenia) and iron overload
This is caused by a deficiency of uroporphyrinogen decarboxylase (UROD)
Porphyria Cutanea Tarda (PCT)
How are UROD level activity diminished?
Iron overload/dysregulation of hepcidin
hepatic iron levels are correlated with clinical expression
What are associated disorders with PCT?
- Alcoholism
- Hemochromatosis
- Hepatitis C